国家高新技术企业
杭州市西湖区优秀创新人才“325”计划入选单位
杭州市高层次人才项目

18668047932    pg2020365

chinasupport@papergoing.com

登录 注册

INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY

ISSN: 1936-2625

官网: http://www.ijcem.com/contents.html

出版商: e-century

Title Scholar cited Year Review Cycle Accept Cycle
Deficiency of calcium and microelements predict the risk of fetal growth restriction. Int J Clin Exp Med 2017;10(5):7491-7499. (Abstract IJCEM0048149, Full text

DOI:

Received:2017-01-04 ; Accepted:2017-01-27 ; Online:2017-05-30

- 2017 0.1 0.8
Panaxatriol saponins attenuate blood-brain barrier disruption in rats following transient middle cerebral artery occlusion. Int J Clin Exp Med 2017;10(5):7521-7532. (Abstract IJCEM0048262, Full text

DOI:

Received:2016-12-05 ; Accepted:2017-03-02 ; Online:2017-05-30

- 2017 2.2 2.9
Combination of icotinib and wogonin induces apoptosis and autophagy to overcome acquired resistance in lung cancer harbouring EGFR T790M mutation. Int J Clin Exp Med 2017;10(5):7553-7562. (Abstract IJCEM0049901, Full text

DOI:

Received:2017-02-01 ; Accepted:2017-03-17 ; Online:2017-05-30

- 2017 0.8 1.5
Resveratrol ameliorates cadmium induced renal oxidative damage and inflammation. Int J Clin Exp Med 2017;10(5):7563-7572. (Abstract IJCEM0051065, Full text

DOI:

Received:2017-02-17 ; Accepted:2017-03-30 ; Online:2017-05-30

- 2017 0.7 1.4
Genistein inhibits glioma cell proliferation and suppresses gD gene expression in HSV-1 infection. Int J Clin Exp Med 2017;10(5):7582-7589. (Abstract IJCEM0050460, Full text

DOI:

Received:2017-02-09 ; Accepted:2017-03-16 ; Online:2017-05-30

- 2017 0.5 1.2
Reversal of cisplatin resistance in ovarian cancer cells mediated by naringin-induced COX-2 expression through the NF-κB signaling pathway. Int J Clin Exp Med 2017;10(5):7590-7596. (Abstract IJCEM0048382, Full text

DOI:

Received:2016-11-06 ; Accepted:2017-02-23 ; Online:2017-05-30

- 2017 2.9 3.6
Serum MALAT1 expression predicts clinical outcome in breast cancer patients receiving cyclophosphamide based treatment. Int J Clin Exp Med 2017;10(5):7624-7635. (Abstract IJCEM0047122, Full text

DOI:

Received:2016-10-02 ; Accepted:2017-03-17 ; Online:2017-05-30

- 2017 4.8 5.5
miRNA-134 suppresses angiotensin II-induced vascular smooth muscle cell dysfunction by targeting angiotensin II type 1 receptor (AT1R). Int J Clin Exp Med 2017;10(5):7658-7667. (Abstract IJCEM0024109, Full text

DOI:

Received:2016-01-15 ; Accepted:2016-04-06 ; Online:2017-05-30

- 2017 2 2.7
ClC5 is upregulated in paclitaxel resistant breast cancer cells and decreases paclitaxel sensitivity via promoting HMGB1 translocation. Int J Clin Exp Med 2017;10(5):7668-7677. (Abstract IJCEM0044442, Full text

DOI:

Received:2016-11-16 ; Accepted:2016-12-21 ; Online:2017-05-30

- 2017 0.5 1.2
Exploration and practice of individualized medical teaching in advanced education based on learning analysis. Int J Clin Exp Med 2017;10(5):7688-7697. (Abstract IJCEM0051022, Full text

DOI:

Received:2017-02-16 ; Accepted:2017-03-07 ; Online:2017-05-30

- 2017 -0.1 0.6